His main research concerns Mycosis, Immunology, Internal medicine, Aspergillosis and Surgery. His study in Mycosis is interdisciplinary in nature, drawing from both Chemotherapy, Retrospective cohort study and Pharmacology. His Immunology research includes elements of Acquired immunodeficiency syndrome and Mycobacterium tuberculosis.
His work deals with themes such as Amphotericin B, Voriconazole, Neutropenia and Intensive care medicine, which intersect with Aspergillosis. His Surgery research is multidisciplinary, incorporating perspectives in Gastroenterology, Adverse effect and Caspofungin. He interconnects Histoplasmosis, Epidemiology and Disease in the investigation of issues within Cryptococcosis.
His primary areas of investigation include Immunology, Mycosis, Internal medicine, Surgery and Cryptococcosis. In his work, Pediatrics is strongly intertwined with Acquired immunodeficiency syndrome, which is a subfield of Immunology. His Mycosis research is multidisciplinary, incorporating perspectives in Chemotherapy, Itraconazole, Fluconazole, Microbiology and Aspergillosis.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Caspofungin. His Surgery study combines topics from a wide range of disciplines, such as Tolerability, Adverse effect and Voriconazole, Posaconazole. He combines subjects such as Meningitis, Epidemiology and Cryptococcus neoformans with his study of Cryptococcosis.
Bertrand Dupont mostly deals with Surgery, Immunology, Intensive care medicine, Internal medicine and Eumycetoma. His research in Surgery intersects with topics in Zygomycosis and Posaconazole. In his works, Bertrand Dupont undertakes multidisciplinary study on Immunology and Immune reconstitution inflammatory syndrome.
The study incorporates disciplines such as Amphotericin B, Micafungin, Pneumocystosis, Invasive candidiasis and Tinea capitis in addition to Intensive care medicine. When carried out as part of a general Amphotericin B research project, his work on Caspofungin is frequently linked to work in Absidia and Lichtheimia corymbifera, therefore connecting diverse disciplines of study. A large part of his Internal medicine studies is devoted to Clinical trial.
Bertrand Dupont focuses on Transplantation, Zygomycosis, Internal medicine, Surgery and Amphotericin B. His study in Transplantation is interdisciplinary in nature, drawing from both Fluorodeoxyglucose, Positron emission tomography, Histoplasmosis, Aspergillosis and Spondylodiscitis. Bertrand Dupont has included themes like Posaconazole, Radiology, Caspofungin and Eumycetoma in his Zygomycosis study.
The various areas that Bertrand Dupont examines in his Internal medicine study include Mucormycosis and Fungemia. Bertrand Dupont combines Surgery and Univariate analysis in his studies. His work carried out in the field of Amphotericin B brings together such families of science as Nephrotoxicity, Relative risk, Adverse effect, Intensive care medicine and Meta-analysis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz.
Voriconazole Treatment for Less-Common, Emerging, or Refractory Fungal Infections
John R. Perfect;Kieren A. Marr;Thomas J. Walsh;Richard N. Greenberg.
Clinical Infectious Diseases (2003)
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
Peter G. Pappas;Coleman M. F. Rotstein;Robert F. Betts;Marcio Nucci.
Clinical Infectious Diseases (2007)
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
A. Skiada;L. Pagano;A. Groll;S. Zimmerli.
Clinical Microbiology and Infection (2011)
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
Thomas J. Walsh;Irja Lutsar;Timothy Driscoll;Bertrand Dupont.
Pediatric Infectious Disease Journal (2002)
Identification of Malassezia species : A practical approach
J. Guillot;E. Gueho;M. Lesourd;G. Midgley.
Journal De Mycologie Medicale (1996)
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner.
Clinical Infectious Diseases (2008)
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Caroline Besson;Aicha Goubar;Jean Gabarre;Willy Rozenbaum.
A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
R. Ally;D. Schürmann;W. Kreisel;G. Carosi.
Clinical Infectious Diseases (2001)
Tuberculosis in HIV-infected patients: a comprehensive review
L. Aaron;D. Saadoun;I. Calatroni;O. Launay.
Clinical Microbiology and Infection (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: